Crossref
journal-article
The Endocrine Society
Endocrinology (80)
References
41
Referenced
29
10.1210/jcem.83.9.5083
/ J Clin Endocrinol Metab / Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. by Baxter (1998)10.1073/pnas.86.18.6898
/ Proc Natl Acad Sci USA / Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: Determination by reconstitution and affinity labeling. by Baxter (1989)10.1016/1043-2760(93)90085-S
/ Trends Endocrinol Metab / Circulating binding proteins for the insulinlike growth factors. by Baxter (1993)10.1016/S0006-291X(88)80824-6
/ Biochem Biophys Res Commun / Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. by De Mellow (1988)10.1210/endo.130.6.1375895
/ Endocrinology / Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. by Conover (1992)10.1038/377646a0
/ Nature / Induction of the growth inhibitor IGF-binding protein 3 by p53. by Buckbinder (1995)10.1210/endo.137.2.8593787
/ Endocrinology / Insulin-like growth factor binding protein-3 inhibits gonadotropin-induced ovulation, oocyte maturation, and steroidogenesis in rabbit ovary. by Yoshimura (1996){'key': '2019041122031767300_R8', 'first-page': '361', 'article-title': 'The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene.', 'volume': '9', 'author': 'Valentinis', 'year': '1995', 'journal-title': 'Mol Endocrinol'}
/ Mol Endocrinol / The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. by Valentinis (1995)10.1210/endo.138.7.5380
/ Endocrinology / The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type I IGF receptor gene. by Zadeh (1997)10.1074/jbc.272.18.12181
/ J Biol Chem / Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. by Rajah (1997)10.1074/jbc.272.41.25602
/ J Biol Chem / Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. by Gill (1997)10.1210/endo.131.4.1382959
/ Endocrinology / Insulin-like growth factor-I (IGF-I) and transforming growth factor-β1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. by Martin (1992)10.1210/endo.131.6.1280212
/ Endocrinology / Non-receptor mediated, post-transcriptional regulation of insulin-like growth factor binding protein (IGFBP)-3 in Hs578T human breast cancer cells. by Oh (1992)10.1210/endo.138.4.5176
/ Endocrinology / Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. by Li (1997)10.1074/jbc.273.29.18347
/ J Biol Chem / Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. by Schedlich (1998)10.1016/S0021-9258(19)84446-0
/ J Biol Chem / Insulin-like growth factor-binding protein from human plasma. Purification and characterization. by Martin (1986)10.1074/jbc.273.5.2631
/ J Biol Chem / Structural determinants of ligand and cell-surface binding of insulin-like growth factor-binding protein-3. by Firth (1998)10.1074/jbc.273.11.6074
/ J Biol Chem / Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit. by Twigg (1998){'key': '2019041122031767300_R19', 'first-page': '1', 'volume': '5', 'author': 'Booth', 'journal-title': 'Growth Regul'}
/ Growth Regul by Booth{'key': '2019041122031767300_R20', 'first-page': 'E321', 'article-title': 'Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3', 'volume': '275', 'author': 'Campbell', 'year': '1998', 'journal-title': 'Am J Physiol'}
/ Am J Physiol / Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3 by Campbell (1998)10.1016/S0303-7207(97)04032-X
/ Mol Cell Endocrinol / Phosphorylation of insulin-like growth factor binding proteins. by Coverley (1997)10.1074/jbc.274.23.16407
/ J Biol Chem / Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells. by Martin (1999)10.1002/jcb.240560220
/ J Cell Biochem / Identification of the major sites of phosphorylation in IGF binding protein-3. by Hoeck (1994)10.1210/endo.136.12.7588336
/ Endocrinology / Regulation of insulin-like growth factor (IGF) binding protein-3 phosphorylation by IGF-I. by Coverley (1995)10.1172/JCI112742
/ J Clin Invest / Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. by Baxter (1986)10.1016/S0021-9258(18)48458-X
/ J Biol Chem / Structural determinants for binary and ternary complex formation between insulin-like growth factor-I (IGF-I) and IGF binding protein-3. by Baxter (1992)10.1210/endo.138.4.5064
/ Endocrinology / Insulin-like growth factor (IGF) binding protein-3 protease activity secreted by MCF-7 breast cancer cells: inhibition by IGFs does not require IGF-IGFBP interaction. by Salahifar (1997)10.1210/endo.136.3.7532580
/ Endocrinology / Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol. by Martin (1995){'key': '2019041122031767300_R29', 'first-page': '237', 'volume-title': 'Insulin-like growth factor binding protein IGFBP-3 is secreted as a phospho-protein', 'author': 'Mukku', 'year': '1991'}
/ Insulin-like growth factor binding protein IGFBP-3 is secreted as a phospho-protein by Mukku (1991)10.3181/00379727-204-43630
/ Proc Soc Exp Biol Med / Regulation and function of insulin-like growth factor-binding protein-1. by Lee (1993)10.1016/S0021-9258(18)54050-3
/ J Biol Chem / Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101. by Jones (1993){'key': '2019041122031767300_R32', 'first-page': '100', 'article-title': 'Insulin-like growth factor binding proteins: biochemical characterization', 'author': 'Baxter', 'year': '1993'}
/ Insulin-like growth factor binding proteins: biochemical characterization by Baxter (1993)10.1042/bj2710773
/ Biochem J / Glycosaminoglycans inhibit formation of the 140 kilodalton insulin-like growth factor-binding protein complex. by Baxter (1990)10.1210/endo.137.10.8828497
/ Endocrinology / Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: role of heparan sulfate proteoglycans. by Yang (1996)10.1016/S0021-9258(19)74273-2
/ J Biol Chem / Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. by Oh (1993)10.1074/jbc.272.33.20572
/ J Biol Chem / The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor. by Leal (1997)10.1210/endo.140.3.6566
/ Endocrinology / Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule. by Yamanaka (1999){'key': '2019041122031767300_R38', 'first-page': '217', 'article-title': 'Regulation of IGF bioavailability by IGFBP proteases', 'author': 'Binoux', 'year': '1994'}
/ Regulation of IGF bioavailability by IGFBP proteases by Binoux (1994){'key': '2019041122031767300_R39', 'first-page': '177', 'article-title': 'Insulin-like growth factor binding protein-3 is functionally normal in pregnancy serum.', 'volume': '74', 'author': 'Suikkari', 'year': '1992', 'journal-title': 'J Clin Endocrinol Metab'}
/ J Clin Endocrinol Metab / Insulin-like growth factor binding protein-3 is functionally normal in pregnancy serum. by Suikkari (1992)10.1210/endo.137.8.8754741
/ Endocrinoogy / A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. by Lalou (1996){'key': '2019041122031767300_R41', 'first-page': 'E465', 'article-title': 'IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding and structure of fragments', 'volume': '271', 'author': 'Booth', 'year': '1996', 'journal-title': 'Am J Physiol'}
/ Am J Physiol / IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding and structure of fragments by Booth (1996)
Dates
Type | When |
---|---|
Created | 11 years, 7 months ago (Jan. 8, 2014, 11:10 a.m.) |
Deposited | 3 years, 5 months ago (March 21, 2022, 7:13 p.m.) |
Indexed | 4 months, 1 week ago (April 22, 2025, 4:11 a.m.) |
Issued | 25 years, 6 months ago (Feb. 1, 2000) |
Published | 25 years, 6 months ago (Feb. 1, 2000) |
Published Print | 25 years, 6 months ago (Feb. 1, 2000) |
@article{Coverley_2000, title={The Effect of Phosphorylation by Casein Kinase 2 on the Activity of Insulin-Like Growth Factor-Binding Protein-3}, volume={141}, ISSN={1945-7170}, url={http://dx.doi.org/10.1210/endo.141.2.7306}, DOI={10.1210/endo.141.2.7306}, number={2}, journal={Endocrinology}, publisher={The Endocrine Society}, author={Coverley, Jennifer A. and Martin, Janet L. and Baxter, Robert C.}, year={2000}, month=feb, pages={564–570} }